STAAR is a developer, manufacturer and marketer of implantable lenses for the eye. Joining its leadership team is James Francese, who will serve as VP of global marketing; Robin Hughes, who will serve as VP of research and development, regulatory and quality; and Craig Felberg, who will serve as VP of business development.
“These leadership transitions are designed to help fuel our revenue growth in three ways: more effectively and aggressively market STAAR products globally, bring new products to market more quickly and evaluate additional new technologies and business opportunities which will allow us to grow within our area of strategic focus,” said CEO Barry Caldwell, in the release.
Mr. Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics and Allergan.
Mr. Hughes has more than 20 years of experience in the ophthalmic industry including the past five as VP of global marketing at STAAR.
Mr. Felberg has 30 years of experience in the ophthalmic surgical business including the past five years as VP of research and development at STAAR.
STAAR Surgical Co. is headquartered in Monrovia, Calif.
Related Articles on Medical Device Companies:
ConvaTec to Acquire Intermittent Catheter Provider 180 Medical Holdings for $321M
Q Urological Set to Launch Pediatric Ureteral Stent
OptiMedica Receives FDA Clearance for Corneal Incisions With Catalys System
